BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 16439470)

  • 21. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
    Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
    Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
    Gujral JS; Liu J; Farhood A; Jaeschke H
    Hepatology; 2004 Oct; 40(4):998-1007. PubMed ID: 15382126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
    Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
    Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
    Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
    Ruf G; Mappes HJ; Koch H; Baumgartner U; Hagmann W; Farthmann EH
    Hepatogastroenterology; 1996; 43(7):121-6. PubMed ID: 8682446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat.
    Zhong Z; Froh M; Wheeler MD; Smutney O; Lehmann TG; Thurman RG
    Gene Ther; 2002 Feb; 9(3):183-91. PubMed ID: 11859421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of fibrogenesis during the early phase of common bile duct obstruction.
    Engin A; Dinçer S; Ercan SZ; Memiş L; Bukan N; Bozkurt S
    ANZ J Surg; 2006 Jul; 76(7):645-8. PubMed ID: 16813633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14.
    Su GL; Goyert SM; Fan MH; Aminlari A; Gong KQ; Klein RD; Myc A; Alarcon WH; Steinstraesser L; Remick DG; Wang SC
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G640-5. PubMed ID: 12181178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
    Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
    Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.
    Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F
    Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
    Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
    Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of CD14 to endotoxin-induced liver injury may depend on types of macrophage activation in rats.
    Toshima K; Mochida S; Ishikawa K; Matsui A; Arai M; Ogata I; Fujiwara K
    Biochem Biophys Res Commun; 1998 May; 246(3):731-5. PubMed ID: 9618280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of time-related changes after experimental bile duct ligation.
    Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
    Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats.
    Aksu B; Umit H; Kanter M; Guzel A; Inan M; Civelek S; Aktas C; Uzun H
    J Pediatr Surg; 2009 Apr; 44(4):702-10. PubMed ID: 19361629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
    Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
    Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.